These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 24794118)
1. Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study. Lamberts M; Lip GY; Ruwald MH; Hansen ML; Özcan C; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH J Am Coll Cardiol; 2014 Jun; 63(24):2689-98. PubMed ID: 24794118 [TBL] [Abstract][Full Text] [Related]
2. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482 [TBL] [Abstract][Full Text] [Related]
3. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760 [TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation. Lee CJ; Pallisgaard JL; Olesen JB; Carlson N; Lamberts M; Gislason GH; Torp-Pedersen C; Brandes A; Husted SE; Johnsen SP; Hansen ML J Am Coll Cardiol; 2017 Jun; 69(24):2901-2909. PubMed ID: 28619189 [TBL] [Abstract][Full Text] [Related]
5. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study. Olesen JB; Lip GY; Lane DA; Køber L; Hansen ML; Karasoy D; Hansen CM; Gislason GH; Torp-Pedersen C Am J Med; 2012 Aug; 125(8):826.e13-23. PubMed ID: 22579139 [TBL] [Abstract][Full Text] [Related]
6. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study. Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375 [TBL] [Abstract][Full Text] [Related]
7. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. Banerjee A; Taillandier S; Olesen JB; Lane DA; Lallemand B; Lip GY; Fauchier L Int J Cardiol; 2013 Sep; 167(6):2682-7. PubMed ID: 22795403 [TBL] [Abstract][Full Text] [Related]
8. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study. Olesen JB; Lip GY; Lindhardsen J; Lane DA; Ahlehoff O; Hansen ML; Raunsø J; Tolstrup JS; Hansen PR; Gislason GH; Torp-Pedersen C Thromb Haemost; 2011 Oct; 106(4):739-49. PubMed ID: 21789337 [TBL] [Abstract][Full Text] [Related]
9. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
10. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation. Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ; Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203 [TBL] [Abstract][Full Text] [Related]
11. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406 [TBL] [Abstract][Full Text] [Related]
12. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512 [TBL] [Abstract][Full Text] [Related]
13. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study. Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497 [TBL] [Abstract][Full Text] [Related]
14. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study. Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606 [TBL] [Abstract][Full Text] [Related]
15. Stroke and major bleeding risk in elderly patients aged ≥75 years with atrial fibrillation: the Loire Valley atrial fibrillation project. Lip GY; Clementy N; Pericart L; Banerjee A; Fauchier L Stroke; 2015 Jan; 46(1):143-50. PubMed ID: 25424474 [TBL] [Abstract][Full Text] [Related]
16. Impact of vascular disease in predicting stroke and death in patients with atrial fibrillation: the Danish Diet, Cancer and Health cohort study. Rasmussen LH; Larsen TB; Due KM; Tjønneland A; Overvad K; Lip GY J Thromb Haemost; 2011 Jul; 9(7):1301-7. PubMed ID: 21535388 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Friberg L; Rosenqvist M; Lip GY Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443 [TBL] [Abstract][Full Text] [Related]
18. Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort. Gundlund A; Xian Y; Peterson ED; Butt JH; Gadsbøll K; Bjerring Olesen J; Køber L; Torp-Pedersen C; Gislason GH; Loldrup Fosbøl E JAMA Netw Open; 2018 May; 1(1):e180171. PubMed ID: 30646049 [TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation: a primary care cross-sectional study. Mashal A; Katz A; Shvartzman P Isr Med Assoc J; 2011 Nov; 13(11):666-71. PubMed ID: 22279699 [TBL] [Abstract][Full Text] [Related]
20. Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study. Bang CN; Gislason GH; Greve AM; Torp-Pedersen C; Køber L; Wachtell K Eur J Prev Cardiol; 2014 Mar; 21(3):330-8. PubMed ID: 23012689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]